Pathfinder
Editor, Senior Moderator
Translation Google
Guangdong approval the second P3 laboratory to carry out H7N9 virus experiment
2013 05 14, 2011 14:13 Source: China News Network
Agency, Guangzhou, May 14 (Reporter Guo Jun) reporter on the 14th from the Guangdong Entry-Exit Inspection and Quarantine Bureau was informed that the Bureau Inspection and Quarantine Technology Center Biosafety 3 laboratory (BSL-3 laboratory, referred to as the P3 laboratory) Recently, the Guangdong Provincial Health Department approval, they can conduct human infection with the H7N9 avian influenza virus experimental activities. Guangdong Province, Sun Yat-sen BSL-3 laboratory obtained the qualification Biosafety three laboratories.
Since February this year, the East China human infection with the H7N9 avian influenza, the Guangdong Provincial Health Department, according to the provincial government's work plan, the prompt start of the response to human infection of H7N9 avian flu research work, the establishment of prevention and control of human infection with the H7N9 poultry influenza epidemic Biosafety group, and organized scientific research, technical training and laboratory bio-safety management, the possibility of a virus mutation detection, identification, diagnostic techniques, carried out in advance.
It is understood that in order to carry out effective drug screening studies on the H7N9 virus, do a good job H7N9 research and special research projects, joint Guangdong Entry-Exit Inspection and Quarantine Technology Center BSL-3 laboratory led by academician Zhong Nanshan Guangzhou Institute of Respiratory Diseases, State Key Laboratory of Respiratory Diseases room, to the Guangdong Provincial Health Department to carry out in accordance with the relevant requirements of human infection with the H7N9 avian influenza virus experimental activities qualification application. Guangdong Provincial Health Department on May 8 BSL-3 laboratory examination and approval Guangdong Inspection and Quarantine Bureau to carry out experimental activities of human infection with the H7N9 avian influenza virus.
Approval, the Guangdong Entry-Exit Inspection and Quarantine Bureau BSL-3 laboratory can carry out virus isolation, culture and identification of the virus screening and experimental detection of the antigen-antibody Chinese medicines, anti-H7N9 virus antibody screening. It is understood that the Guangdong Entry-Exit Inspection and Quarantine Bureau and co-operation with the Guangzhou Institute of Respiratory Diseases, a joint application of the H7N9 avian influenza virus strains will be served on the laboratory, and immediately commenced the H7N9 avian influenza virus research laboratory.
Guangdong Entry-Exit Inspection and Quarantine Bureau BSL-3 laboratory is only one Chinese inspection and quarantine system approved BSL-3 laboratory, has detected the first imported cases of Chikungunya fever in China (Guangdong Province, the first Chinese port's first cases) confirmed cases of influenza A (H1N1). (End)
http://www.chinanews.com/jk/2013/05-14/4816461.shtml
Guangdong approval the second P3 laboratory to carry out H7N9 virus experiment
2013 05 14, 2011 14:13 Source: China News Network
Agency, Guangzhou, May 14 (Reporter Guo Jun) reporter on the 14th from the Guangdong Entry-Exit Inspection and Quarantine Bureau was informed that the Bureau Inspection and Quarantine Technology Center Biosafety 3 laboratory (BSL-3 laboratory, referred to as the P3 laboratory) Recently, the Guangdong Provincial Health Department approval, they can conduct human infection with the H7N9 avian influenza virus experimental activities. Guangdong Province, Sun Yat-sen BSL-3 laboratory obtained the qualification Biosafety three laboratories.
Since February this year, the East China human infection with the H7N9 avian influenza, the Guangdong Provincial Health Department, according to the provincial government's work plan, the prompt start of the response to human infection of H7N9 avian flu research work, the establishment of prevention and control of human infection with the H7N9 poultry influenza epidemic Biosafety group, and organized scientific research, technical training and laboratory bio-safety management, the possibility of a virus mutation detection, identification, diagnostic techniques, carried out in advance.
It is understood that in order to carry out effective drug screening studies on the H7N9 virus, do a good job H7N9 research and special research projects, joint Guangdong Entry-Exit Inspection and Quarantine Technology Center BSL-3 laboratory led by academician Zhong Nanshan Guangzhou Institute of Respiratory Diseases, State Key Laboratory of Respiratory Diseases room, to the Guangdong Provincial Health Department to carry out in accordance with the relevant requirements of human infection with the H7N9 avian influenza virus experimental activities qualification application. Guangdong Provincial Health Department on May 8 BSL-3 laboratory examination and approval Guangdong Inspection and Quarantine Bureau to carry out experimental activities of human infection with the H7N9 avian influenza virus.
Approval, the Guangdong Entry-Exit Inspection and Quarantine Bureau BSL-3 laboratory can carry out virus isolation, culture and identification of the virus screening and experimental detection of the antigen-antibody Chinese medicines, anti-H7N9 virus antibody screening. It is understood that the Guangdong Entry-Exit Inspection and Quarantine Bureau and co-operation with the Guangzhou Institute of Respiratory Diseases, a joint application of the H7N9 avian influenza virus strains will be served on the laboratory, and immediately commenced the H7N9 avian influenza virus research laboratory.
Guangdong Entry-Exit Inspection and Quarantine Bureau BSL-3 laboratory is only one Chinese inspection and quarantine system approved BSL-3 laboratory, has detected the first imported cases of Chikungunya fever in China (Guangdong Province, the first Chinese port's first cases) confirmed cases of influenza A (H1N1). (End)
http://www.chinanews.com/jk/2013/05-14/4816461.shtml